|1.||Manabe, Tadao: 5 articles (06/2007 - 07/2003)|
|2.||Funahashi, Hitoshi: 5 articles (06/2007 - 07/2003)|
|3.||Sawai, Hirozumi: 5 articles (06/2007 - 07/2003)|
|4.||Hayakawa, Tetsushi: 4 articles (06/2007 - 07/2003)|
|5.||Matsuo, Yoichi: 4 articles (06/2007 - 07/2003)|
|6.||Okada, Yuji: 4 articles (06/2007 - 07/2003)|
|7.||Tanaka, Moritsugu: 3 articles (06/2007 - 01/2004)|
|8.||Takeyama, Hiromitsu: 3 articles (06/2007 - 11/2005)|
|9.||Harris, R Adron: 1 article (08/2015)|
|10.||Mayfield, Jody: 1 article (08/2015)|
|1.||Genetic Predisposition to Disease (Genetic Predisposition)
01/01/2006 - "Neuronal interleukin-1 receptor type I expression in the hippocampus outlasted the duration of spontaneous electroencephalographic seizure and was not observed in degenerating neurons. "
01/01/2006 - "In this study, we investigated the basal and seizure-induced expression of interleukin-1 receptor type I in rat forebrain to identify the cells targeted by interleukin-1beta during epileptic activity. "
|3.||Habitual Abortion (Recurrent Miscarriage)
01/01/2007 - "This study sought to compare the endometrial expression of interleukin-1 receptor type I in patients with a history of spontaneous recurrent miscarriage and patients with unsuccessful IVF cycles. "
01/01/2007 - "Endometrial expression of interleukin-1 receptor type I does not seem to be involved in embryo implantation in IVF patients, but may play a role in spontaneous recurrent miscarriage."
12/01/2012 - "The interleukin 1 receptor, type I (IL1R1) is important in the pathogenesis of cancer. "
03/01/2006 - "We analyzed the expression of p53 protein, proliferating cell nuclear antigen, alpha6-integrin subunit, alpha5beta1-integrin, and interleukin-1 receptor type I in tumor specimens from eight patients with MCT. "
06/01/2007 - "We carried out immunohistochemical staining for p53 protein, proliferating cell nuclear antigen (PCNA), integrins, and interleukin-1 receptor type I (IL-1RI) in order to investigate the degree of malignancy of this neoplasm in addition to the immunohistochemical analyses that were necessary for diagnosing GIST. "
11/01/2005 - "Although immunoreactivity against p53 was negative, strong positive immunostaining for proliferating cell nuclear antigen and interleukin-1 receptor type I (IL-1RI) was observed in a the majority of tumor cells, while the alpha6 integrin subunit was predominantly strong expressed in the adenocarcinomatous lesion. "
01/01/2004 - "We immunohistochemically analyzed the expression of p53 protein, proliferating cell nuclear antigen, alpha6-integrin subunit, alpha5beta1 integrin, and interleukin-1 receptor type I in tumor specimens from the 23 patients with IPMT. "
|5.||Breast Neoplasms (Breast Cancer)
02/01/2014 - "Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer."
01/01/2014 - "Expression levels of nine NILCO and targets [Notch1, Notch4, JAG1, DLL4, VEGF, VEGFR2 (FLK-1), leptin, leptin receptor (OB-R) and interleukin-1 receptor type I (IL-1R tI)] were examined via immunohistochemistry in breast cancer tissue microarrays from Chinese patients (ER+, n=33; ER-, n=21; TNBC, n=13) and non-malignant breast tissue (n=5; Pantomics, Inc.) using a semi-quantitative analysis of intensity staining, HSCORE. "
|1.||Interleukin-1 (Interleukin 1)
|2.||Interleukin-1beta (Interleukin 1 beta)
|3.||Ethanol (Ethyl Alcohol)
|4.||Proliferating Cell Nuclear Antigen (PCNA)
|6.||Messenger RNA (mRNA)